Perceptive Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-178,797
Closed -$9.13M – 115
2024
Q4
$9.13M Buy
+178,797
New +$8.79M 0.25% 65
2022
Q4
– Sell
-70,000
Closed -$5.08M – 112
2022
Q3
$5.08M Buy
+70,000
New +$5.21M 0.15% 81
2022
Q2
– Sell
-30,000
Closed -$2.72M – 129
2022
Q1
$2.72M Buy
+30,000
New +$2.46M 0.05% 113
2021
Q3
– Sell
-310,437
Closed -$29M – 159
2021
Q2
$29M Sell
310,437
-254,676
-45% -$24.7M 0.38% 61
2021
Q1
$60.5M Sell
565,113
-103,387
-15% -$10.7M 0.76% 36
2020
Q4
$58.4M Sell
668,500
-180,000
-21% -$12.7M 0.63% 40
2020
Q3
$58.6M Buy
848,500
+152,500
+22% +$9.81M 0.86% 32
2020
Q2
$33.7M Buy
+696,000
New +$33.2M 0.55% 45

Other funds holding NARI

Perceptive Advisors's NARI Position: Q1 2025 in Review

Perceptive Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 178,797 shares — an estimated $9.13M sold.

Perceptive Advisors first reported a position in NARI in Q2 2020 and held it in 8 quarters. The position peaked at $60.5M in Q1 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Perceptive Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Perceptive Advisors sold 178,797 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $9.13M.
  • Perceptive Advisors first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • Perceptive Advisors's Inari Medical, Inc. Common Stock position peaked at $60.5M in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Perceptive Advisors's 13F filing for Q1 2025, filed 15 May 2025.